Author:
Chen Cheng,Chen Hao,Wu Lingli,Gong Qin,He Jingchun
Abstract
Abstract
Background
Antiretroviral Therapy (ART) is pivotal in extending the lives of people living with HIV (PLWH) and minimizing transmission. Rapid ART initiation, defined as commencing ART within seven days of HIV diagnosis, is recommended for all PLWH.
Method
A retrospective cohort study was conducted using data from the China Information System for Disease Control and Prevention. This study included PLWH diagnosed between January 2018 and December 2021 and treated by December 2022. Factors influencing rapid ART initiation were examined using univariate and multivariate Cox regression analyses.
Results
The study analyzed 1310 cases. The majority were male (77.4%), over 50 years old (46.7%), and contracted HIV through heterosexual transmission (70.0%). Rapid ART initiation was observed in 36.6% (n = 479) of cases, with a cumulative treatment rate of 72.9% within 30 days post-diagnosis. Heterosexual contact was associated with longer intervals from diagnosis to treatment initiation compared to homosexual contact (Adjusted Hazard Ratio (HR) = 0.813, 95% Confidence Interval (CI): 0.668–0.988). Individuals older than 50 years (Adjusted HR = 1.852, 95%CI: 1.149–2.985) were more likely to initiate ART rapidly. Conversely, treatment at the Second Public Hospital (Adjusted HR = 0.483, 95% CI: 0.330–0.708) and a CD4 cell counts above 500 (Adjusted HR = 0.553, 95% CI: 0.332–0.921) were associated with a lower likelihood of initiating treatment within seven days.
Conclusions
A higher CD4 cell counts and receiving care in local public hospitals may deter rapid ART initiation. Providing CD4 counts results at diagnosis and offering testing and treatment in the same facility could enhance the rate of rapid ART initiation.
Funder
The first batch of key disciplines on public health in Chongqing
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Joint United Nations Programme on HIV/AIDS, Global HIV. & AIDS statistics. Fact sheet. 2023. https://www.unaids.org/en/resources/fact-sheet. Accessed 27 Dec 2023.
2. GBD HIV Collaborators. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the global burden of diseases Study 2019[J]. Lancet HIV. 2021;8:e633–51.
3. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel[J]. JAMA. 2002;288:222–35.
4. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization. 2015. https://iris.who.int/handle/10665/186275. Accessed 27 Dec 2023.
5. World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy[EB/OL]. 2017. https://www.who.int/publications/i/item/9789241550062. Accessed 15 Dec 2023.